Year: 2018
-
School of Medicine students to take part in ethics fellowship
Two Vanderbilt University School of Medicine (VUSM) students were recently chosen by the Fellowships at Auschwitz for the Study of Professional Ethics (FASPE) to participate in a two-week program in Germany and Poland that uses the conduct of physicians in Nazi-occupied Europe as a way to reflect on medical ethics today. Read MoreApr 19, 2018
-
MIT’s Orr-Weaver wraps up spring Discovery Lecture series April 26
The spring Flexner Discovery Lecture series wraps up on Thursday, April 26, with a presentation by Terry Orr-Weaver, PhD, professor of Biology at the Massachusetts Institute of Technology. Read MoreApr 19, 2018
-
Ingram sees recent cancer diagnosis as second chance
“When it’s you, it’s a whole different feeling,” Orrin Ingram said, gazing at logs burning in the fireplace. Read MoreApr 19, 2018
-
New labeling system speeds clinical lab turnaround times
Much of everyday clinical decision-making is informed by lab tests performed rapidly on automated instrumentation — basic metabolic panels, complete blood counts, all the lab orders for which clinicians expect quick results. Read MoreApr 19, 2018
-
VUMC drug repurposing initiative gaining momentum
Drug repurposing involves establishing an additional approved indication for a drug already at market. Read MoreApr 19, 2018
-
Friends & Fashion raises funds in style for Children’s Hospital
Current and former patients of Monroe Carell Jr. Children’s Hospital at Vanderbilt walked the runway alongside professional models at the annual Friends & Fashion event at Music City Center April 9. Read MoreApr 19, 2018
-
Fleming elected to vision commission
Geoffrey Fleming, MD, associate professor of Pediatrics, has been selected to serve on the Continuing Board Certification’s Vision Initiative Commission. Read MoreApr 19, 2018
-
Characterizing ‘keyhole’ is first step to fighting obesity at the cellular level
A Vanderbilt team and their international colleagues characterized for the first time a complex, little-understood cellular receptor type that, when activated, shuts off hunger. Read MoreApr 18, 2018
-
Initiative stresses importance of advance directives
While many might prefer to not think about dying, healthcare professionals throughout the United States are encouraging patients and their families to do just that during a national awareness campaign April 16-22 that promotes the importance of completing an advance directive for healthcare. Read MoreApr 12, 2018
-
Agreement renewal bolsters liver tumor research
Sirtex Medical Ltd. has renewed a grant award to Dan Brown, MD, professor of Radiology and Radiological Sciences and chief of Interventional Oncology, and his Vanderbilt Health colleagues, for a research program designed to treat patients with liver tumors that cannot be addressed with surgery. Read MoreApr 12, 2018
-
Nobel laureate Kobilka’s talk explores receptor activation
Brian Kobilka, MD, who received the 2012 Nobel Prize in Chemistry for his studies of G protein-coupled receptors (GPCRs), shared his team’s progress in understanding receptor activation — and how that might guide drug development — at last week’s Flexner Discovery Lecture. Read MoreApr 12, 2018
-
VICC breast cancer leaders named Komen Scholars
Ingrid Mayer, MD, MSCI, Ingram Professor of Cancer Research and leader of the Breast Cancer Research Program at Vanderbilt-Ingram Cancer Center (VICC), has been named a Komen Scholar for her leadership in breast cancer research. Read MoreApr 12, 2018
-
Entertainers’ support strengthens VICC melanoma research efforts
Henry Paul and Dave Robbins, members of country music group BlackHawk, as well as southern rock band The Outlaws, recently donated $40,000 to Vanderbilt-Ingram Cancer Center (VICC) in support of melanoma research. Since 2006, the band members have generated more than $100,000 for VICC. Read MoreApr 12, 2018
-
Johns to help guide PM&R certification process
Jeffery Johns, MD, medical director of Vanderbilt Stallworth Rehabilitation Hospital, has been elected to the board of directors of the American Board of Physical Medicine and Rehabilitation. Read MoreApr 12, 2018
-
Research lab honored by World Vaccine Congress
The laboratory of James Crowe Jr., MD, director of the Vanderbilt Vaccine Center, received the 2018 Vaccine Industry Excellence Award for Best Academic Research Team at the 18th World Vaccine Congress in Washington, DC, this week. Read MoreApr 12, 2018
-
Radix set for upcoming VUSN Dean’s Diversity Lecture
Asa Radix, MD, MPH, an internationally recognized medical expert and researcher on the health needs of transgender and LGBTQ people, will give the Vanderbilt University School of Nursing (VUSN) Dean’s Diversity Lecture on Monday, May 7, noon-1 p.m., in VUSN’s Nursing Annex room 155. Read MoreApr 12, 2018
-
VICC to host symposium on neurofibromatosis April 21
Vanderbilt-Ingram Cancer Center (VICC) will host a special event for patients and families affected by neurofibromatosis (NF), a genetic disorder that can cause tumors in the nervous system. The Neurofibromatosis Patient and Family Symposium will be held Saturday, April 21, 9 a.m. – 1 p.m., at the VICC 8th floor conference center in the Preston Research Building, 2220 Pierce Ave. Read MoreApr 12, 2018
-
3-D model gives clearer picture of complex cases
Elizabeth and Scott Massey expected to learn their baby’s gender at a 21-week ultrasound. While they learned they were having a daughter, the reveal included much more than they planned for. Read MoreApr 12, 2018
-
Event honors impact of organ, eye and tissue donation
Every 10 minutes someone is added to the national organ transplant wait list. Read MoreApr 12, 2018
-
Alpha-gal found to be both a medication and red meat allergy
Alpha-gal allergy has commonly been referred to as “the red meat” allergy, but doctors at the Vanderbilt Asthma, Sinus and Allergy Program (ASAP) helped uncover that not only red meat, but some medications, can contain alpha-gal. Read MoreApr 12, 2018